Aflac (AFL) to Announce Quarterly Earnings on Thursday

by · The Markets Daily

Aflac (NYSE:AFL – Get Free Report) is expected to release its Q2 2026 results after the market closes on Thursday, August 6th. Analysts expect Aflac to announce earnings of $1.76 per share and revenue of $4.1066 billion for the quarter. Investors can find conference call details on the company’s upcoming Q2 2026 earning results page for the latest details on the call scheduled for Friday, August 7, 2026 at 8:00 AM ET.

Aflac Trading Down 1.3%

Shares of NYSE:AFL traded down $1.59 during trading on Tuesday, reaching $125.12. The company’s stock had a trading volume of 515,138 shares, compared to its average volume of 2,352,247. The stock has a market capitalization of $63.68 billion, a PE ratio of 14.20, a price-to-earnings-growth ratio of 1.97 and a beta of 0.60. Aflac has a 12 month low of $97.47 and a 12 month high of $130.22. The company has a current ratio of 0.11, a quick ratio of 0.11 and a debt-to-equity ratio of 0.26. The firm’s 50 day simple moving average is $119.82 and its two-hundred day simple moving average is $114.97.

Insider Activity

In other news, major shareholder Post Holdings Co. Ltd. Japan sold 63,000 shares of the company’s stock in a transaction that occurred on Friday, June 5th. The stock was sold at an average price of $118.12, for a total transaction of $7,441,560.00. Following the transaction, the insider owned 51,169,435 shares of the company’s stock, valued at approximately $6,044,133,662.20. This represents a 0.12% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 744,916 shares of company stock worth $87,118,632 in the last ninety days. 0.80% of the stock is owned by insiders.

Hedge Funds Weigh In On Aflac

Several hedge funds have recently bought and sold shares of the business. Compound Planning Inc. increased its stake in Aflac by 2.6% in the 4th quarter. Compound Planning Inc. now owns 13,652 shares of the financial services provider’s stock worth $1,505,000 after buying an additional 347 shares during the period. Axxcess Wealth Management LLC boosted its position in Aflac by 359.8% in the 4th quarter. Axxcess Wealth Management LLC now owns 10,433 shares of the financial services provider’s stock valued at $1,150,000 after buying an additional 8,164 shares during the period. Birchwood Financial Partners Inc. purchased a new stake in Aflac in the 4th quarter valued at about $36,000. Corient Private Wealth LLC grew its stake in Aflac by 6.1% in the 4th quarter. Corient Private Wealth LLC now owns 558,689 shares of the financial services provider’s stock worth $58,629,000 after acquiring an additional 32,329 shares in the last quarter. Finally, Mercer Global Advisors Inc. ADV grew its stake in Aflac by 2.3% in the 4th quarter. Mercer Global Advisors Inc. ADV now owns 258,224 shares of the financial services provider’s stock worth $28,304,000 after acquiring an additional 5,767 shares in the last quarter. Institutional investors own 67.44% of the company’s stock.

Analyst Ratings Changes

A number of equities research analysts have issued reports on the company. Wells Fargo & Company upped their price objective on Aflac from $111.00 to $120.00 and gave the company an “equal weight” rating in a research report on Thursday, July 9th. Weiss Ratings raised Aflac from a “buy (b+)” rating to a “buy (a-)” rating in a research report on Thursday, July 23rd. Jefferies Financial Group restated a “hold” rating and set a $108.00 price target (up from $100.00) on shares of Aflac in a report on Friday, July 10th. UBS Group restated a “neutral” rating and set a $124.00 price target (up from $114.00) on shares of Aflac in a report on Wednesday, July 8th. Finally, Barclays lowered their price target on Aflac from $99.00 to $98.00 and set an “underweight” rating for the company in a research report on Tuesday, July 7th. Two equities research analysts have rated the stock with a Strong Buy rating, two have given a Buy rating, seven have issued a Hold rating and two have given a Sell rating to the company’s stock. According to MarketBeat.com, Aflac currently has a consensus rating of “Hold” and an average target price of $116.17.

Get Our Latest Analysis on AFL

Aflac Company Profile

(Get Free Report)

Aflac Incorporated (American Family Life Assurance Company of Columbus) is a provider of supplemental insurance products designed to help policyholders manage out-of-pocket health care and living expenses. The company underwrites a range of individual and group policies that typically pay cash benefits directly to insureds when covered events occur, enabling greater financial flexibility for medical treatment, hospital stays, critical illness, and related costs. Aflac’s product mix includes supplemental health insurance, life insurance and other specialty coverages intended to complement primary medical plans.

Founded in the mid-20th century and headquartered in Columbus, Georgia, Aflac distributes its products through a combination of employer-sponsored programs, independent brokers and agents, and direct marketing.

Further Reading